Cell-mediated side effects of psychopharmacological treatment

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 10, 2001, Pages 785-792

  Maurer, I ^a   Volz, H P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antidepressants, cell mediated side effects; Neuroleptics, cell mediated side effects; Psychopharmacology, receptor interaction, side effects

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; DESIPRAMINE; DOPAMINE RECEPTOR; DOXEPIN; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; HISTAMINE H1 RECEPTOR ANTAGONIST; IMIPRAMINE; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; NORADRENALIN; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; RECEPTOR SUBTYPE; RISPERIDONE; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOTEPINE;

AKATHISIA; ANXIETY NEUROSIS; BRAIN SYNAPTOSOME; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DYSTONIA; ENERGY METABOLISM; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; NAUSEA; NONHUMAN; PARKINSONISM; PATHOGENESIS; PSYCHOPHARMACOTHERAPY; RAT; RESPIRATORY CHAIN; REVIEW; SCHIZOIDISM; SCHIZOPHRENIA; SLEEP DISORDER; TARDIVE DYSKINESIA;

EID: 0034772654     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300116     Document Type: Review

References (36)

1. Depression: A long-term illness and its treatment
2. Fluoxetine versus moclobemide: Cross-comparison between the time courses of improvement
3. Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses
4. Blockade by antidepressants and related compounds of biogenic amine uptake into rat synaptosomes: Most antidepressants selectively block norepinephrine uptake
5. Blockade by newly developed antidepressants of biogenic amine uptake into rat synaptosomes
6. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro
7. Binding of antidepressants to human brain receptors: Focus on newer generation compounds
8. Histamine receptors in the central nervous system
9. 3-receptors
10. The pharmacology of antidepressants at the synapse: Focus on newer compounds
11. The safety of fluoxetine - An update
12. Serotonergic mechanisms and current and future psychiatric practice
13. Factors influencing relapse in the long-term course of schizophrenia
14. 38 Cas de psychoses traités par la cure prolongée et continuée de 4568 R.P.
15. Clozapine effects on tardive dyskinesia
16. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison versus chlorpromazine/benztropine
17. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine
18. Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: Correlative evaluation by positron emission tomography and plasma prolactin levels
19. Neurobiological substrates of tardive dyskinesia: The GABA hypothesis
20. Evidence for mitochondrial dysfunction in Parkinson's disease - A critical appraisal
21. Mitochondrial oxidative phosphorylation defects in Parkinson's disease
22. Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats
23. Neuroleptic medications inhibit complex I of the electron transport chain
24. Effect of neuroleptics on the mitochondrial electron transport chain
25. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
26. Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics
27. Clozapine: Neuroleptic-induced EPS and tardive dyskinesia
28. Effect of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridene (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat
29. 35-chlorpromazine in brain
30. 35S-chlorpromazine in mice studied by whole body autoradiography
31. 35S-chlorpromazine in the neuromelanin of human substantia nigra and locus coeruleus
32. Blood to brain distribution of neuroleptics
33. Pharmakokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzothiepine (zotepine) in rat, mouse, dog and man
34. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity
35. Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenthixol) in rats
36. Mitochondrial genetics: A paradigm for aging and degenerative diseases?